Today: 9 June 2026
Ondas Stock Is Moving Again After a $199 Million AI Defense Deal — What Investors Missed

Ondas Stock Is Moving Again After a $199 Million AI Defense Deal — What Investors Missed

New York, May 20, 2026, 12:21 EDT

Ondas Inc. shares rose in midday trading on Wednesday as investors weighed the company’s planned purchase of Israeli defense software firm Omnisys against a stock that has already had a sharp defense-drone run. The shares recently traded up 3.3% at $9.43, after touching $9.47, with about 22.0 million shares changing hands.

The reason this matters now is not just another acquisition. Ondas is trying to move further into software-defined defense systems, where unmanned aircraft, sensors and command software are tied together for faster battlefield decisions. The company said on Monday it had agreed to buy 100% of Omnisys, whose Battle Resource Optimization software, or BRO, helps plan and allocate defense resources in real time.

A filing showed the Omnisys deal carries a $199 million stock purchase price, with up to $60 million more in contingent earn-out payments, also payable in stock. The deal is expected to close in the second quarter, but it still faces closing conditions including government approvals and employee-retention requirements. That is the risk paragraph: stock-funded deals can dilute holders, and the strategic case depends on Ondas integrating another asset quickly enough to justify the new shares.

Needham kept a Buy rating and a $23 price target on Ondas after the announcement, saying the deal adds a software orchestration layer to the company’s autonomous systems portfolio. The firm estimated Omnisys could add $30 million to $40 million in pro forma 2026 revenue, with more upside in 2027 if Ondas expands the product across allied defense markets.

Company executives used careful but pointed language. Chief Executive Eric Brock called BRO a “battle-tested software platform,” while Oshri Lugassy, co-chief executive of Ondas Autonomous Systems, said the deal could enable “closed-loop operations” linking sensors, platforms and effectors. Omnisys CEO Ofer Yarden said the company would use Ondas’ reach to expand BRO internationally.

The deal lands less than a week after Ondas reported first-quarter revenue of $50.1 million, up 1,065% from a year earlier, and raised its 2026 revenue target to at least $390 million. The company said pro forma backlog reached $457 million, while adjusted EBITDA — earnings before interest, taxes, depreciation and amortization, excluding some items — was still a loss of $10.9 million.

Brock said the backlog gave Ondas “strong visibility into our 2026 targets.” The phrase matters because the company is still spending ahead of revenue, with operating expenses rising as it folds in acquisitions and builds a larger defense platform. Ondas Inc.

Defense and drone-related peers also traded higher. The iShares U.S. Aerospace & Defense ETF rose 2.4%, while AeroVironment gained 1.0%, Kratos Defense rose 3.8% and Karman Holdings added 0.8%. That helped the tape, but Ondas’ move stayed tied mainly to its own deal flow and guidance reset.

The next test is less about the headline number and more about delivery. Investors now have to see whether Omnisys adds profitable software revenue, whether Ondas can keep adjusted EBITDA losses from widening further, and whether the backlog turns into shipments on the timetable management has laid out.

Stock Market Today

  • Nasdaq Chipmakers Rally as OpenAI Files for IPO Amid Market Rebound
    June 9, 2026, 9:47 AM EDT. Nasdaq chipmakers led Wall Street's rebound after last week's tech sell-off, with Nvidia, AMD, Micron, and Broadcom recovering losses. Futures rose ahead of key US inflation data due Wednesday and Thursday, which investors see as crucial for Federal Reserve's interest rate outlook. Oil prices eased below $90 a barrel, easing inflation worries and supporting risk appetite. Asian markets rallied, notably Seoul's Kospi up 8.2%, while European markets were mixed. In company news, OpenAI filed confidentially for an IPO, eyeing an autumn listing, following anticipated floats from SpaceX and Anthropic. US small business optimism slipped in May, missing forecasts, but economists noted survey limitations.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
MARA Holdings Stock Gains as Bitcoin Recovery and AI Plans Run Into Morgan Stanley Downgrade
Previous Story

MARA Holdings Stock Gains as Bitcoin Recovery and AI Plans Run Into Morgan Stanley Downgrade

OpenAI IPO Filing Could Come Soon as ChatGPT Parent Moves Fast Toward Market Debut
Next Story

OpenAI IPO Filing Could Come Soon as ChatGPT Parent Moves Fast Toward Market Debut

Go toTop